Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype?

Genetics in Medicine

Volumn 6, Issue 1, 2004, Pages 1-15

  Acosta, Maria Teresa ^a,b   Arcos Burgos, Mauricio ^b   Muenke, Maximilian ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Autism; Epistasis; Pleiotropy; Schizophrenia

Indexed keywords

ATTENTION DEFICIT DISORDER; COMORBIDITY; CULTURAL FACTOR; DEVELOPMENTAL DISORDER; ENVIRONMENTAL FACTOR; EPISTASIS; FEMALE; GENE CLUSTER; GENE SEGREGATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC TRAIT; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; PLEIOTROPY; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; EPIDEMIOLOGIC STUDIES; GENOTYPE; HUMANS; INCIDENCE; MODELS, GENETIC; PHENOTYPE;

EID: 0842349087     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000110413.07490.0B     Document Type: Review

References (195)

1. Witte JS, Elston RC, Schork NJ. Genetic dissection of complex traits. Nat Gene 1996;12:355-356
2. Elston RC. Introduction and overview: Statistical methods in genetic epidemiology. Stat Methods Med Res 2000;9:527-541.
3. Ober C, Abney M, McPeek MS. The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001;69:1068-1079.
4. Asherson P, Curran S. Approaches to gene mapping in complex disorders and their application in child psychiatry and psychology. Br J Psychiatry 2001;179:122-128.
5. Castellanos FX, Tannock R. Neuroscience of attention-deficit hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002;3:617-628.
6. Stevenson J, Pennington BF, Gilger JW, DeFries JC, Gillis JJ. Hyperactivity and spelling disability: testing for shared genetic aetiology. J Child Psychol Psychiatry 1993;34:1137-1152.
7. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:564-577.
8. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992;49:728-738.
9. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998;44:269-273.
10. Scahill L, Schwab-Stone M, Merikangas KR, Leckman JF, Zhang H, Kasl S. Psychosocial and clinical correlates of ADHD in a community sample of school-age children. J Am Acad Child Adolesc Psychiatry 1999;38:976-984.
11. Milberger S, Faraone SV, Biederman J, Chu MP, Wilens T. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders. Arch Pediatr Adolesc Med 1998;152:945-951.
12. Arcos-Burgos M, Castellanos FX, Lopera F, Pineda D, Palacio JD, Garcia M et al. Attention-deficit/hyperactivity disorder (ADHD). Feasibility of linkage analysis in a genetic isolate using extended and multigenerational pedigrees. Clin Genet 2002;61:335-343.
13. Lopera F, Palacio LG, Jimenez I, Villegas P, Puerta IC, Pineda D et al. Genetic and environmental factors discrimination in attention deficit hyperactivity disorder. Rev Neurol 1999;28:660-664.
14. Maher BS, Marazita ML, Moss HB, Vanyukov MM. Segregation analysis of attention deficit hyperactivity disorder. Am J Med Genet 1999;88:71-78.
15. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C et al. Segregation analysis of attention deficit hyperactivity disorder. Psychiatr Genet 1992;2:257-275.
16. Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001;58:289-295.
17. Solanto MV, Arnsten AFT, Castellanos FX. The neuroscience of stimulant drug action in ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: Basic and clinical neuroscience. New York: Oxford University Press, 2001;355-379.
18. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002;288:1740-1748.
19. Wortis J. Struwwelpeter Heinrich Hoffmann (1809-1894). Biol Psychiatry 1988;24:615-618.
20. Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev 2002;8:162-170.
21. American Psychiatric Association. Diagnostic, and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM III-R). American Psychiatric Association, Washington DC, 1987.
22. American Psychiatric Association. Diagnostic, and Statistical Manual of Mental Disorders. Fourth Edition (DSM IV) American Psychiatric Association, Washington DC, 1994.
23. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study: Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 1996;35:865-877.
24. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents: Council on Scientific Affairs, American Medical Association. JAMA 1998;279:1100-1107.
25. Cantwell DP. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996;35:978-987.
26. Cantwell DP. Classification of child and adolescent psychopathology. J Child Psychol Psychiatry 1996;37:3-12.
27. Hinshaw SP. On the distinction between attentional deficits/ hyperactivity and conduct problems/aggression in child psychopathology. Psychol Bull 1987;101:443-463.
28. Barkley RA, Cook EH, Diamond A, Zametkin A, Thapar A, Teeter A et al. International consensus statement on ADHD, January 2002. Clin Child Fam Psychol Rev 2002;5:89-111.
29. Murphy R, Barkley A, Bush. Young adults with attention deficit hyperactivity disorder: Subtype differences in comorbidity, educational, and clinical history. J Nerv Ment Dis 2002;190:147-157.
30. Swanson JM, Castellanos FX. Diagnosis, and Treatment of Attention Deficit Hyperactivity Disorder (ADHD). Biological bases of ADHD: neuroanatomy, genetics, and pathophysiology. NIH Consens Statement 1998;16:1-37.
31. Willcutt EG, Pennington BF, Smith SD, Cardon LR, Gayan J, Knopik VS et al. Quantitative trait locus for reading disability on chromosome 6p is pleiotropic for attention-deficit/hyperactivity disorder. Am J Med Genet 2002;114:260-268.
32. Gillis JJ, Gilger JW, Pennington BF, DeFries JC. Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnorm Child Psychol 1992;20:303-314.
33. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997;36:737-744.
34. Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behav Gene 1992;22:337-344.
35. Curran S, Rijsdijk F, Martin N, Marusic K, Asherson P, Taylor E et al. CHIP. Defining a dimension of the vulnerability to attention deficit hyperactivity disorder (ADHD) using sibling and individual data of children in a community-based sample. A J Med Genet 2003;119B:86-97.
36. Rasmussen ER, Neuman RJ, Heath AC, Levy F, Hay DA, Todd RD. Replication of the latent class structure of Attention-Deficit Hyperactivity Disorder (ADHD) subtypes in a sample of Australian twins. J Child Psychol Psychiatry 2002;43:1018-1028.
37. Rasmussen ER, Todd RD, Neuman RJ, Heath AC, Reich W, Rohde LA. Comparison of male adolescent-report of attention-deficit/hyperactivity disorder (ADHD) symptoms across two cultures using latent class and principal components analysis. J Child Psychol Psychiatry 2002;43:797-805.
38. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1996;35:343-351.
39. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1143-1146.
40. Harada Y, Satoh Y, Sakuma A, Imai J, Tamaru T, Takahashi T et al. Behavioral and developmental disorders among conduct disorder. Psychiatry Clin Neurosci 2002;56:621-625.
41. Harada Y, Yamazaki T, Saitoh K. Psychosocial problems in attention-deficit hyperactivity disorder with oppositional defiant disorder. Psychiatry Clin Neurosci 2002;56:365-369.
42. Geller B, Zimerman B, Williams M, DelBello MP, Frazier J, Beringer L. Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality. J Child Adolesc Psychopharmacol 2002;12:3-9.
43. Faraone SV, Biederman J, Monuteaux MC. Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for a familial subtype? J Affect Disord 2001;64:19-26.
44. Chang KKD, Steiner H, Ketter TA. Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry 2000;39:453-460.
45. Giedd JN. Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents. J Clin Psychiatry 2000;61:1-34.
46. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:525-540, vii.
47. Roberts N, Parker KCH, Woogh C, Cripps L, Froese AP. Bipolar disorder in ADHD children grown up. J Am Acad Child Adolesc Psychiatry 2000;39:678-679.
48. Sachs GS, Baldassano CF, Truman CJ, Guille C. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 2000;157:466-468.
49. Stein MA, Roizen NM, Leventhal BL. Bipolar disorder and ADHD. J Am Acad Child Adolesc Psychiatry 1999;38:1208-1209.
50. Kurlan R, Como PG, Miller B, Palumbo D, Deeley C, Andresen EM et al. The behavioral spectrum of tic disorders: A community-based study. Neurology 2002;59:414-420.
51. Comings DE. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann N Y Acad Sci 2001;931:50-83.
52. Como PG. Neuropsychological function in Tourette syndrome. Adv Neuro 2001;85:103-111.
53. Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 2001;40:685-695.
54. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. Tourette disorder and ADHD. Adv Neural 2001;85:57-77.
55. Friedman MC, Chhabildas N, Budhiraja N, Willcutt EG, Pennington BF. Etiology of the comorbidity between RD and ADHD: Exploration of the non-random mating hypothesis. Am J Med Genet 2003;120B:109-115.
56. Faraone SV, Biederman J, Friedman D. Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective. J Am Acad Child Adolesc Psychiatry 2000;39:300-307.
57. Willcutt EG, Pennington BF. Comorbidity of reading disability and attention-deficit/hyperactivity disorder: Differences by gender and subtype. J Learn Disabil 2000;33:179-191.
58. Willcutt EG, Hartung CM, Lahey BB, Loney J, Pelham WE. Utility of behavior ratings by examiners during assessments of preschool children with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol 1999;27:463-472.
59. Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH. Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder. Br J Psychiatry 2002;181:416-421.
60. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry 1996;35:1213-1226.
61. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997;36:21-29.
62. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol 2000;18:1-16.
63. Simkin DR. Adolescent substance use disorders and comorbidity. Pediatr Clin North Am 2002;49:463-477.
64. Wilson JJ, Levin FR. Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Curr Psychiatry Rep 2001;3:497-506.
65. Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, Kelley BJ et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000;61:244-251.
66. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565-576.
67. Faraone SV, Biederman J, Mennin D, Russell R, Tsuang MT. Familial subtypes of attention deficit hyperactivity disorder: A 4-year follow-up study of children from antisocial-ADHD families. J Child Psychol Psychiatry 1998;39:1045-1053.
68. Smalley SL, McCracken J, McGough J. Refining the ADHD phenotype using affected sibling pair families. Am J Med Genet 2001;105:31-33.
69. Lahey BB, Schaughency EA, Hynd GW, Calrson CL, Nieves N. Attention deficit disorder with and without hyperactivity: Comparison of behavioral characteristics of clinic-referred children. J Am Acad Child Adolesc Psychiatry 1987;26:718-723.
70. Biederman J. Attention-deficit/hyperactivity disorder: A life-span perspective. J Clin Psychiatry 1998;59:4-16.
71. Gaub M, Carlson CL. Gender differences in ADHD: A meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997 36;1036-1045:
72. Rowland AS, Umbach DM, Catoe KE, Stallone L, Long S, Rabiner D, Naftel AJ, Panke D, Faulk R, Sandler DP. Studying the epidemiology of attention-deficit hyperactivity disorder: Screening method and pilot results. Can J Psychiatry 2001;46:931-940.
73. Morrison JR, Stewart MA. A family study of the hyperactive child syndrome. Biol Psychiatry 1971;3:189-195.
74. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-1517.
75. Risch N, Merikangas K. Genetic analysis of complex diseases. Science 1997;275:1329-1330.
76. Risch N. Linkage strategies for genetically complex traits, II: The power of affected relative pairs. Am J Hum Genet 1990;46:229-241.
77. Faraone SV. Report from the third international meeting of the Attention-Deficit Hyperactivity Disorder Molecular Genetics Network. Am J Med Genet 2002;114:272-276.
78. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 2002;70:1183-1196.
79. Ogdie MN, MacPhie IL, Minassian SL, Yang M, Fisher SE, Francks C et al. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet 2003;72:1268-1279.
80. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/ hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 2003;72:1251-1260.
81. Arcos-Burgos M, Muenke M. Genetics of population isolates. Clin Genet 2002;61:233-247.
82. Bravo ML, Montoya JE, Arcos-Burgos M. Polymorphisms of classical markers, genetic structure and phenetic relationships of a black community inhabiting Choco State in Colombia. Homo 2000;51:132-140.
83. Carvajal-Carmonan LG, Ophoff R, Service S, Hartiala J, Molina J, Leon P et al. Genetic demography of Antioquia (Colombia) and the Central Valley of Costa Rica. Hum Genet 2003;112:534-541.
84. Arcos-Burgos M, Castellanos FX, Lopera F, Pineda D, Palacio JD, Rapoport JL et al. Genome-wide scan in multigenerational and extended pedigrees segregating ADHD from a genetic isolate. Am J Hum Genet 2003;73:476
85. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1052-1057.
86. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002;12:207-215.
87. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 2003;8:299-308.
88. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 2001;6:425-428.
89. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Gene 1998;63:1767-1776.
90. Galili-Weisstub E, Segman RH. Attention Deficit and Hyperactivity Disorder: Review of genetic association studies. Isr J Psychiatry Relat Sci 2003;40:57-66.
91. Arcos-Burgos M, Castellanos FX, Konecki D, Lopera F, Pineda D, Palacio JD et al. Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate. Mol Psychiatry In press.
92. Mill J, Fisher N, Curran S, Richards S, Taylor E, Asherson P. Polymorphisms in the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Neuroreport 2003;14:1463-1466.
93. Seaman MI, Fisher JB, Chang F, Kidd KK. Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). Am J Med Genet 1999;88:705-709.
94. McCracken IT, Smalley SL, McGough JJ, Crawford L, Del'Homme M, Cantor RM et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000;5:531-536.
95. LaHoste GJ, Swanson M, Wigal SB, Glabe C, King N, Kennedy JL et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;1:121-124.
96. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R et al. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 2003;119B:77-85.
97. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-β-hydroxylase gene. Am J Med Genet 2002;114:154-158.
98. Wiggm K, Zai G, Schachar R, Tannock R, Roberts W, Malone M et al. Attention deficit hyperactivity disorder and the gene for dopamine beta-hydroxylase. Am J Psychiatry 2002;159:1046-1048.
99. Bowden CL, Deutsch CK, Swanson JM. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. J Am Acad Child Adolesc Psychiatry 1988;27:171-174.
100. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M et al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 2002;7:626-632.
101. Jiang S, Xin R, Lin S, Qian Y, Tang G, Wang D et al. Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am J Med Genet 2001;105:783-788.
102. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N et al. Dopaminergic system genes in ADHD: Toward a biological hypothesis. Neuropsychopharmacology 2002;27:607-619.
103. Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ. No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet 2000;96:285-288.
104. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W et al. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 1999;88:710-713.
105. Eisenberg J, Mei-Tal G, Steinberg, A, Tartakovsky E, Zohar A, Gritsenko I et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 1999;88:497-502.
106. Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SF. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol Psychiatry 2003;8:309-315.
107. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): Evidence of linkage and association in the Irish population. Mol Psychiatry 2002;7:913-917.
108. Raber J, Mehta PP, Kreifeldt M, Parsons LH, Weiss F, Bloom FE et al. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem 1997;68:176-186.
109. Hess EJ, Collins KA, Wilson MC. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci 1996;16:3104-3111.
110. Steffensen SC, Wilson MC, Henriksen SJ. Coloboma contiguous gene deletion encompassing SNAP alters hippocampal plasticity. Synapse 1996;22:281-289.
111. Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z et al. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Psychiatry 2002;7:908-912.
112. Retz W, Thome J, Blocher D, Baader M, Sler M. Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism. Neurosci Lett 2002;319:133-136.
113. Cottingham Jr RW, Idury RM, Schaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet 1993;53:252-263.
114. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus analysis in humans. Proc Natl Acad Sci U S A 1984;81:3443-3446.
115. Sobel E, Lange, K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker sharing statistics. Am J Hum Genet 1996;58:1323-1337.
116. Minde K, Eakin L, Hechtman L, Ochs E, Bouffard R, Greenfield B et al. The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry 2003;44:637-646.
117. Niederhofer H, Hackenberg B, Stier R, Lanzendorfer K, Kemmler G, Lechner T. Features in families of boys with hyperkinetic and emotional disorders. Psychol Rep 2003;92:849-852.
118. Pliszka R. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 1989;28:882-887.
119. Jensen PS, Arnold LE, Richters JE, Severe JB, Vereen D, Vitiello B et al. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-1086.
120. Pauls DL, Bailey JN, Carter AS, Allen CR, Egeland JA. Complex segregation analyses of old order Amish families ascertained through bipolar I individuals. Am J Med Genet 1995;60:290-297.
121. Blangero J, Elston RC. Familial analysis of bipolar affective disorder using logistic models. Genet Epidemiol 1989;6:221-227.
122. Sham PC, Morton NE, Muir WJ, Walker M, Collins A, Shields DC et al. Segregation analysis of complex phenotypes: an application to schizophrenia and auditory P300 latency. Psychiatr Gene 1994;4:29-38.
123. Risch N, Baron M. Segregation analysis of schizophrenia and related disorders. Am J Hum Genet 1984;36:1039-1059.
124. Ruiz A, Blanco R, Arcos M, Santander J, San Martin A. Complex segregation analysis of schizophrenia in Santiago, Chile. Schizophr Res 1997;26:65-69.
125. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 1999;88:38-43.
126. Pauls DL, Pakstis AJ, Kurlan R, Kidd KK, Leckman JF, Cohen DJ et al. Segregation and linkage analyses of Tourette's syndrome and related disorders. J Am Acad Child Adolesc Psychiatry 1990;29:195-203.
127. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance. Am J Hum Genet 1996;59:684-693.
128. Berquin PC, Giedd N, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL et al. The cerebellum in attention-deficit/hyperactivity disorder: a morphometric study. Neurology 1998;50:1087-1093.
129. Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC, Hamburger SD et al. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:665-669.
130. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:1791-1796.
131. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP et al. Quantitative brain magnetic resonance imaging in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1996;53:607-616.
132. Castellanos FX, Sharp WS, Gottesman RF, Greenstein DK, Giedd JN, Rapoport JL. Anatomic brain abnormalities in monozygotic twins discordant for attention-deficit/hyperactivity disorder. Am J Psychiatry 2003;160:1693-1696.
133. Mostofsky SH, Cooper KL, Kates WR, Denckla MB, Kaufmann WE. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 2002;52:785-794.
134. Hesslinger B, Tebartz VE, Thiel T, Haegele K, Hennig J, Ebert D. Frontoorbital volume reductions in adult patients with attention deficit hyperactivity disorder. Neurosci Lett 2002;328:319-321.
135. Hynd GW, Hern KL, Novey ES, Eliopulos D, Marshall R, Gonzalez J et al. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339-347.
136. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H. Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI. J Learn Disabil 1991;24:141-146.
137. Durston S, Tottenham NT, Thomas KM, Davidson MC, Eigsti IM, Yang Y et al. Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatry 2003;53:871-878.
138. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber, HW, Desmond JE, Glover GH et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A 1998;95:14494-14499.
139. El Sayed E, Larsson JO, Persson HE, Rydelius PA. Altered cortical activity in children with attention-deficit/hyperactivity disorder during attentional load task. J Am Acad Child Adolesc Psychiatry 2002;41:811-819.
140. Kim BN, Lee JS, Shin MS, Cho SC, Lee DS. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder: Statistical parametric mapping analysis. Eur Arch Psychiatry Clin Neurosci 2002;252:219-225.
141. Koth CW, Cutting LE, Denckla MB. The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Neuropsychol Dev Cogn Sect C Child Neuropsychol 2000;6:185-194.
142. Heussler HS, Suri M, Young ID, Muenke M. Extreme variability of expression of a Sonic Hedgehog mutation: Attention difficulties and holoprosencephaly. Arch Dis Child 2002;86:293-296.
143. McCauley E, Kay T, Ito J, Treder R. The Turner syndrome: Cognitive deficits, affective discrimination, and behavior problems. Child Dev 1987;58:464-473.
144. McCauley E, Sybert VP, Ehrhardt AA. Psychosocial adjustment of adult women with Turner syndrome. Clin Genet 1986;29:284-290.
145. McCauley E, Ito J, Kay T. Psychosocial functioningin girls with Turner's syndrome and short stature: social skills, behavior problems, and self-concept. J Am Acad Child Psychiatry 1986;25:105-112.
146. Hoogenraad CC, Koekkoek B, Akhmanova A, Krugers H, Dortland B, Miedema M et al. Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice. Nat Genet 2002;32L:116-127.
147. Bawden HN, MacDonald GW, Shea S. Treatment of children with Williams syndrome with methylphenidate. J Child Neurol 1997;12:248-252.
148. Backes M, Genc B, Schreck J, Doerfler W, Lehmkuhl G, von Gontard A. Cognitive and behavioral profile of fragile X boys: Correlations to molecular data. Am J Med Genet 2000;95:150-156.
149. Blair IP, Gibson RR, Bennett CL, Chance PF. Search for genes involved in Joubert syndrome: evidence that one or more major loci are yet to be identified and exclusion of candidate genes EN1, EN2, FGF8, and BARHL1. Am J Med Genet 2002;107:190-196.
150. Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, Killian J et al. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet 1996;62:247-254.
151. Greenberg F, Guzzetta V, Montes DOL, Magenis RE, Smith AC, Richter SF et al. Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet 1991;49:1207-1218.
152. Smith AC, Dykens E, Greenberg F. Sleep disturbance in Smith-Magenis syndrome (del 17p11.2). Am J Med Genet 1998;81:186-191.
153. Smith AC, Dykens E, Greenberg F. Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2). Am J Med Genet 1998;81:79-185.
154. Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Sergeant JA. Short-term dietary interventions in children and adolescents with treated phenylketonuria: effects on neuropsychological outcome of a well-controlled population. J Inherit Metab Dis 2002;25:419-430.
155. Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 2002;40:7-15.
156. Ullrich K, Weglage J, Oberwittler C, Pietsch M, Funders B, von Eckardstein Colombo JP. Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. Eur J Pediatr 1996;155(suppl 1):S74-S77.
157. Weglage J, Schmidt E, Funders B, Pietsch M, Ullrich K. Sustained attention in untreated non-PKU-hyperphenylalaninemia. J Clin Exp Neuropsychol 1996;18:343-348.
158. Weglage J, Fundersm B, Ullrich K, Rupp A, Schmidt E. Psychosocial aspects in phenylketonuria. Eur J Pediatr 1996;155(suppl 1):S101-S104.
159. O'Malley KD, Nanson J. Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorder. Can J Psychiatry 2002;47:349-354.
160. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg, C. Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects. Dev Med Child Neurol 2002;44:44-50.
161. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet Med 2001;3:79-84.
162. Graf WD, Unis AS, Yates CM, Sulzbacher S, Dinulos MB, Jack RM et al. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology 2001;57:410-416.
163. Bloom DR, Levin, HS, Ewing-Cobbs L, Saunders AE, Song J, Fletcher JM et al. Lifetime and novel psychiatric disorders after pediatric traumatic brain injury. J Am Acad Child Adolesc Psychiatry 2001;40:572-579.
164. Slomine BS, Gerring JP, Grados MA, Vasa R, Brady KD, Christensen JR et al. Performance on measures of executive function following pediatric traumatic brain injury. Brain Inj 2002;16:759-772.
165. Anderson SW, Damasio H, Tranel D, Damasio AR. Long-term sequelae of prefrontal cortex damage acquired in early childhood. Dev Neuropsychol 2000;18:281-296.
166. DeLong GR. Mid-gestation right basal ganglia lesion: clinical observations in two children. Neurology 2002;59:54-58.
167. Pineda DA, Lopera F, Henao GC, Palacio JD, Castellanos FX. [Confirmation of the high prevalence of attention deficit disorder in a Colombian community]. Rev Neurol 2001;32:217-222.
168. Vasconcelos MM, Werner J Jr, Malheiros AF, Lima DF, Santos IS, Barbosa JB. [Attention deficit/hyperactivity disorder prevalence in an inner city elementary school]. Arq Neuropsiquiatr 2003;61:67-73.
169. Pineda DA, Lopera F, Palacio JD, Ramirez D, Henao GC. Prevalence estimations of attention-deficit/hyperactivity disorder: Differential diagnoses and comorbidities in a Colombian sample. Int J Neurosci 2003;113:49-71.
170. Benjasuwantep B, Ruangdaraganon N, Visudhiphan P. Prevalence and clinical characteristics of attention deficit hyperactivity disorder among primary school students in Bangkok. J Med Assoc Thai 2002;85 Suppl 4:S1232-S1240.
171. Breton J, Bergeron L, Valla JP, Berthiaume C, Gaudet N, Lambert J et al. Quebec child mental health survey: prevalence of DSM-III-R mental health disorders. J Child Psychol Psychiatry 1999;40:375-384.
172. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996;35:319-324.
173. Baumgaertel A, Wolraich ML, Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 1995;34:629-638.
174. Pelham WE Jr, Gnagy EM, Greenslade KE, Milich R. Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 1992;31:210-218.
175. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme MA et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:427-430.
176. Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN et al. Lack of association between a dopamine-4 receptor polymorphism and attention- deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry 1998;3:431-434.
177. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998;3:38-41.
178. Rowe DC, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, Terris ST et al. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:419-426.
179. Comings DE, Gonzalez N, Wu SJ, Gade R, Muhleman D, Saucier G et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 1999;88:358-368.
180. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 1999;156:768-770.
181. Eisenberg J, Zohar A, Mei-Tal G, Steinberg A, Tartakovsky E, Gritsenko I et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) Exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Genet 2000;96:258-261.
182. Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet 2000;96:268-272.
183. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 2000;5:523-530.
184. Kotler M, Manor I, Sever Y, Eisenberg J, Cohen H, Ebstein RP et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet 2000;96:278-281.
185. Muglia P, Jain U, Macciardi F, Kennedy JL. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 2000;96:273-277.
186. Muglia P, Jain U, Basile VS, Kennedy JL. Adult ADHD: Association with the dopamine D4 receptor gene. Am J Hum Genet 1999;65:A462.
187. Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000;5:396-404.
188. Sunohara GA, Roberts W, Malone M, Schachar RJ, Tannock R, Basile VS et al. Linkage of the dopamine D4 receptor gene and attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000;39:1537-1542.
189. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Gene 2000;96:282-284.
190. Manor I, Kotler M, Sever Y, Eisenberg J, Cohen H, Ebstein RP et al. Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet 2000;96:858-860.
191. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R et al. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000;5:537-54.
192. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer, JE et al. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993-998.
193. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997;2:311-313.
194. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry 2001;49:333-339.
195. Mill J, Curran S, Kent L, Gould A, Huckett L, Richards S et al. Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Genet 2002;114:269-271.